Global CD40 Ligand Market Status and Outlook 2018-2025

August 2018 | 154 pages | ID: GE9BC560E7EEN
99Strategy

Abstracts

REPORT SNAPSHOT

Key Content of Chapters (Including and can be customized, report is a semifinished version, and it takes 48-72 hours to upgrade)

Part 1:
Terminology Definition, Industry Chain,Industry Dynamics & Regulations and Global Market Overview
Part 2:
Upstream (Raw Materials/Components) & Manufacturing (Procurement Methods & Channels and Cost), Major Regional Production Overview and Trade Flow
Part 3:
Product Segment Overview and Market Status
Part 4:
Application/End-User Segment Overview and Market Status
Part 5:
Region Segment Overview and Market Status
Part 6:
Product & Application Segment Production & Demand by Region
Part 7:
Market Forecast by Product, Application & Region
Part 8:
Company information, Products & Services and Business Operation (Sales, Cost, Margin etc.)
Part 9:
Market Competition and Environment for New Entrants
Part 10:
Conclusion

Market Segment as follows:

Key Companies

• Biogen, Inc.
• Bristol-Myers Squibb Company
• eTheRNA Immunotherapies NV
• ImmuNext, Inc.
• Juno Therapeutics Inc.
• MedImmune, LLC
• Targovax AS
• XL-protein GmbH

Market by Type

• ISF-35
• LOAd-700
• MEDI-4920
• MegaCD40L
• Others

Market by Application

• Hepatitis B
• Bladder Cancer
• Liver Cancer
• Ovarian Cancer
• Others

Contents

PART 1 INDUSTRY OVERVIEW (200 USD)

1.1 CD40 Ligand Industry
  1.1.1 Market Development
  1.1.2 Terminology Definition in the Report
    1.1.2.1 Production
    1.1.2.2 Demand
    1.1.2.3 Sales Revenue
    1.1.2.4 Ex-factory Price & Sales Price
    1.1.2.5 Cost
    1.1.2.6 Gross Margin
1.2 Products & Services Scope
1.3 Industry Chain
1.4 Industry Dynamics & Regulations
1.5 Global Market Overview

PART 2 UPSTREAM & PRODUCTION (200 USD)

2.1 Raw Materials / Components
2.2 Procurement Methods & Channels
2.3 Cost Structure & Manufacturing
2.4 Industry Capacity
2.5 Production Distribution by Geography
  2.5.1 Production in Major Regions / Countries
  2.5.2 Trade Flow Overview

PART 3 PRODUCT SEGMENT (400 USD)

3.1 Introduction by Type
  3.1.1 ISF-35
  3.1.2 LOAd-700
  3.1.3 MEDI-4920
  3.1.4 MegaCD40L
  3.1.5 Others
3.2 Market Status

PART 4 APPLICATION / END-USER SEGMENT (400 USD)

4.1 Introduction by Application
  4.1.1 Hepatitis B
  4.1.2 Bladder Cancer
  4.1.3 Liver Cancer
  4.1.4 Ovarian Cancer
  4.1.5 Others
4.2 Market Status

PART 5 REGIONAL MARKET (600 USD)

5.1 Market Overview
5.2 by Region
  5.2.1 North America
    5.2.1.1 United States Market Size and Growth (2015-2018E)
    5.2.1.2 Canada Market Size and Growth (2015-2018E)
    5.2.1.3 Mexico Market Size and Growth (2015-2018E)
  5.2.2 Europe
    5.2.2.1 Germany Market Size and Growth (2015-2018E)
    5.2.2.2 UK Market Size and Growth (2015-2018E)
    5.2.2.3 France Market Size and Growth (2015-2018E)
    5.2.2.4 Italy Market Size and Growth (2015-2018E)
    5.2.2.5 Spain Market Size and Growth (2015-2018E)
    5.2.2.6 Netherlands Market Size and Growth (2015-2018E)
    5.2.2.7 Poland Market Size and Growth (2015-2018E)
    5.2.2.8 Belgium Market Size and Growth (2015-2018E)
    5.2.2.9 Sweden Market Size and Growth (2015-2018E)
    5.2.2.10 Austria Market Size and Growth (2015-2018E)
    5.2.2.11 Denmark Market Size and Growth (2015-2018E)
    5.2.2.12 Switzerland Market Size and Growth (2015-2018E)
    5.2.2.13 Russia Market Size and Growth (2015-2018E)
  5.2.3 Asia-Pacific
    5.2.3.1 China Market Size and Growth (2015-2018E)
    5.2.3.2 India Market Size and Growth (2015-2018E)
    5.2.3.3 Japan Market Size and Growth (2015-2018E)
    5.2.3.4 Korea Market Size and Growth (2015-2018E)
    5.2.3.5 Australia Market Size and Growth (2015-2018E)
    5.2.3.6 Indonesia Market Size and Growth (2015-2018E)
    5.2.3.7 Thailand Market Size and Growth (2015-2018E)
    5.2.3.8 Malaysia Market Size and Growth (2015-2018E)
    5.2.3.9 Singapore Market Size and Growth (2015-2018E)
    5.2.3.10 Philippines Market Size and Growth (2015-2018E)
  5.2.4 South America
    5.2.4.1 Brazil Market Size and Growth (2015-2018E)
    5.2.4.2 Argentina Market Size and Growth (2015-2018E)
    5.2.4.3 Columbia Market Size and Growth (2015-2018E)
    5.2.4.4 Chile Market Size and Growth (2015-2018E)
    5.2.4.5 Peru Market Size and Growth (2015-2018E)
    5.2.4.6 Puerto Rico Market Size and Growth (2015-2018E)
    5.2.4.7 Ecuador Market Size and Growth (2015-2018E)
  5.2.5 Middle East
    5.2.5.1 Saudi Arabia Market Size and Growth (2015-2018E)
    5.2.5.2 Iran Market Size and Growth (2015-2018E)
    5.2.5.3 UAE Market Size and Growth (2015-2018E)
    5.2.5.4 Oman Market Size and Growth (2015-2018E)
    5.2.5.5 Kuwait Market Size and Growth (2015-2018E)
    5.2.5.6 Iraq Market Size and Growth (2015-2018E)
    5.2.5.7 Turkey Market Size and Growth (2015-2018E)
  5.2.6 Africa
    5.2.6.1 South Africa Market Size and Growth (2015-2018E)
    5.2.6.2 Egypt Market Size and Growth (2015-2018E)
    5.2.6.3 Nigeria Market Size and Growth (2015-2018E)
    5.2.6.4 Algeria Market Size and Growth (2015-2018E)
    5.2.6.5 Angola Market Size and Growth (2015-2018E)
    5.2.6.6 Morocco Market Size and Growth (2015-2018E)
    5.2.6.7 Sultan Market Size and Growth (2015-2018E)

PART 6 MARKET SUBDIVISION (800 USD)

6.1 Regional Production
  6.1.1 Production by Type
    6.1.1.1 ISF-35 Production by Region
    6.1.1.2 LOAd-700 Production by Region
    6.1.1.3 MEDI-4920 Production by Region
    6.1.1.4 MegaCD40L Production by Region
    6.1.1.5 Others Production by Region
  6.1.2 Production by Application
    6.1.2.1 Hepatitis B Production by Region
    6.1.2.2 Bladder Cancer Production by Region
    6.1.2.3 Liver Cancer Production by Region
    6.1.2.4 Ovarian Cancer Production by Region
    6.1.2.5 Others Production by Region
6.2 Regional Demand
  6.2.1 Demand by Type
    6.2.1.1 ISF-35 Demand by Region
    6.2.1.2 LOAd-700 Demand by Region
    6.2.1.3 MEDI-4920 Demand by Region
    6.2.1.4 MegaCD40L Demand by Region
    6.2.1.5 Others Demand by Region
  6.2.2 Demand by Application
    6.2.2.1 Hepatitis B Demand by Region
    6.2.2.2 Bladder Cancer Demand by Region
    6.2.2.3 Liver Cancer Demand by Region
    6.2.2.4 Ovarian Cancer Demand by Region
    6.2.2.5 Others Demand by Region

PART 7 MARKET FORECAST (200 USD)

7.1 Global Forecast
7.2 Forecast by Type
7.3 Forecast by Application
7.4 Forecast by Region

PART 8 KEY COMPANIES LIST (600 USD)

8.1 Biogen, Inc.
  8.1.2 Company Information
  8.1.2 Products & Services
  8.1.3 Business Operation
8.2 Bristol-Myers Squibb Company
  8.2.1 Company Information
  8.2.2 Products & Services
  8.2.3 Business Operation
8.3 eTheRNA Immunotherapies NV
  8.3.1 Company Information
  8.3.2 Products & Services
  8.3.3 Business Operation
8.4 ImmuNext, Inc.
  8.4.1 Company Information
  8.4.2 Products & Services
  8.4.3 Business Operation
8.5 Juno Therapeutics Inc.
  8.5.1 Company Information
  8.5.2 Products & Services
  8.5.3 Business Operation
8.6 MedImmune, LLC
  8.6.1 Company Information
  8.6.2 Products & Services
  8.6.3 Business Operation
8.7 Targovax AS
  8.7.1 Company Information
  8.7.2 Products & Services
  8.7.3 Business Operation
8.8 XL-protein GmbH
  8.8.1 Company Information
  8.8.2 Products & Services
  8.8.3 Business Operation

PART 9 COMPANY COMPETITION (500 USD)

9.1 Market by Company
9.2 Price & Gross Margin
9.3 Competitive Environment for New Entrants
  9.3.1 Michael Porter's Five Forces Model
  9.3.2 SWOT

PART 10 RESEARCH CONCLUSION (100 USD)

List Of Tables

LIST OF TABLES

Table CD40 Ligand Industry Dynamics & Regulations List
Table Global CD40 Ligand Sales Revenue, Cost and Margin, 2015-2018E
Table Global CD40 Ligand Market Status by Type 2015-2018E, in USD Million
Table Global CD40 Ligand Market Status by Application 2015-2018E, in USD Million
Table Global CD40 Ligand Market Status by Application 2015-2018E, in Volume
Table Global CD40 Ligand Market by Region 2015-2018E, in USD Million
Table Global CD40 Ligand Market Share by Region in 2018, in USD Million
Table Global CD40 Ligand Market by Region 2015-2018E, in Volume
Table Global CD40 Ligand Market Share by Region in 2018, in Volume
Table ISF-35 Production Value by Region 2015-2018E, in USD Million
Table ISF-35 Production Volume by Region 2015-2018E, in Volume
Table LOAd-700 Production Value by Region 2015-2018E, in USD Million
Table LOAd-700 Production Volume by Region 2015-2018E, in Volume
Table MEDI-4920 Production Value by Region 2015-2018E, in USD Million
Table MEDI-4920 Production Volume by Region 2015-2018E, in Volume
Table MegaCD40L Production Value by Region 2015-2018E, in USD Million
Table MegaCD40L Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table Hepatitis B Production Value by Region 2015-2018E, in USD Million
Table Hepatitis B Production Volume by Region 2015-2018E, in Volume
Table Bladder Cancer Production Value by Region 2015-2018E, in USD Million
Table Bladder Cancer Production Volume by Region 2015-2018E, in Volume
Table Liver Cancer Production Value by Region 2015-2018E, in USD Million
Table Liver Cancer Production Volume by Region 2015-2018E, in Volume
Table Ovarian Cancer Production Value by Region 2015-2018E, in USD Million
Table Ovarian Cancer Production Volume by Region 2015-2018E, in Volume
Table Others Production Value by Region 2015-2018E, in USD Million
Table Others Production Volume by Region 2015-2018E, in Volume
Table ISF-35 Market Size by Region 2015-2018E, in USD Million
Table ISF-35 Market Size by Region 2015-2018E, in Volume
Table LOAd-700 Market Size by Region 2015-2018E, in USD Million
Table LOAd-700 Market Size by Region 2015-2018E, in Volume
Table MEDI-4920 Market Size by Region 2015-2018E, in USD Million
Table MEDI-4920 Market Size by Region 2015-2018E, in Volume
Table MegaCD40L Market Size by Region 2015-2018E, in USD Million
Table MegaCD40L Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table Hepatitis B Market Size by Region 2015-2018E, in USD Million
Table Hepatitis B Market Size by Region 2015-2018E, in Volume
Table Bladder Cancer Market Size by Region 2015-2018E, in USD Million
Table Bladder Cancer Market Size by Region 2015-2018E, in Volume
Table Liver Cancer Market Size by Region 2015-2018E, in USD Million
Table Liver Cancer Market Size by Region 2015-2018E, in Volume
Table Ovarian Cancer Market Size by Region 2015-2018E, in USD Million
Table Ovarian Cancer Market Size by Region 2015-2018E, in Volume
Table Others Market Size by Region 2015-2018E, in USD Million
Table Others Market Size by Region 2015-2018E, in Volume
Table GlobalCD40 Ligand Forecast by Type 2019F-2025F, in USD Million
Table CD40 Ligand Forecast by Type 2019F-2025F, in Volume
Table CD40 Ligand Market Forecast by Application / End-User 2019F-2025F, in USD Million
Table CD40 Ligand Market Forecast by Application / End-User 2019F-2025F, in Volume
Table CD40 Ligand Market Forecast by Region 2019F-2025F, in USD Million
Table CD40 Ligand Market Forecast by Region 2019F-2025F, in Volume
Table Biogen, Inc. Information
Table CD40 Ligand Sales, Cost, Margin of Biogen, Inc.
Table Bristol-Myers Squibb Company Information
Table CD40 Ligand Sales, Cost, Margin of Bristol-Myers Squibb Company
Table eTheRNA Immunotherapies NV Information
Table CD40 Ligand Sales, Cost, Margin of eTheRNA Immunotherapies NV
Table ImmuNext, Inc. Information
Table CD40 Ligand Sales, Cost, Margin of ImmuNext, Inc.
Table Juno Therapeutics Inc. Information
Table CD40 Ligand Sales, Cost, Margin of Juno Therapeutics Inc.
Table MedImmune, LLC Information
Table CD40 Ligand Sales, Cost, Margin of MedImmune, LLC
Table Targovax AS Information
Table CD40 Ligand Sales, Cost, Margin of Targovax AS
Table XL-protein GmbH Information
Table CD40 Ligand Sales, Cost, Margin of XL-protein GmbH
Table Global CD40 Ligand Sales Revenue by Company 2015-2017, in USD Million
Table Global CD40 Ligand Sales Volume by Company 2015-2017, in Volume
Table Global CD40 Ligand Sales Volume by Company in 2018, in Volume

List Of Figures

LIST OF FIGURES

Figure CD40 Ligand Picture
Figure CD40 Ligand Industry Chain Diagram
Figure Global CD40 Ligand Sales Revenue 2015-2018E, in USD Million
Figure Global CD40 Ligand Sales Volume 2015-2018E, in Volume
Figure Global CD40 Ligand Market Status by Type 2015-2018E, in Volume
Figure North America CD40 Ligand Market Size and Growth 2015-2018E, in USD Million
Figure North America CD40 Ligand Market Size and Growth 2015-2018E, in Volume
Figure Europe CD40 Ligand Market Size and Growth 2015-2018E, in USD Million
Figure Europe CD40 Ligand Market Size and Growth 2015-2018E, in Volume
Figure Asia-Pacific CD40 Ligand Market Size and Growth 2015-2018E, in USD Million
Figure Asia-Pacific CD40 Ligand Market Size and Growth 2015-2018E, in Volume
Figure South America CD40 Ligand Market Size and Growth 2015-2018E, in USD Million
Figure South America CD40 Ligand Market Size and Growth 2015-2018E, in Volume
Figure Middle East CD40 Ligand Market Size and Growth 2015-2018E, in USD Million
Figure Middle East CD40 Ligand Market Size and Growth 2015-2018E, in Volume
Figure Africa CD40 Ligand Market Size and Growth 2015-2018E, in USD Million
Figure Africa CD40 Ligand Market Size and Growth 2015-2018E, in Volume
Figure Global CD40 Ligand Sales Revenue Forecast 2019F-2025F, in USD Million
Figure Global CD40 Ligand Sales Volume Forecast 2019F-2025F, in Volume
Figure Global CD40 Ligand Sales Price Forecast 2019F-2025F
Figure Global CD40 Ligand Gross Margin Forecast 2019F-2025F
Figure Global CD40 Ligand Sales Revenue by Company in 2018, in USD Million
Figure Global CD40 Ligand Price by Company in 2018
Figure Global CD40 Ligand Gross Margin by Company in 2018